
28 August 2008: Announcement no. 2, 2008: Zealand Pharma today announced that Dr. David H...
Zealand's Pipeline comprises 1 compound in phase III, 2 compounds in phase II, 3 compounds ...
Zealand focuses intensively on holding a broad covering and very solid patent portfolio that ensures maximum protection of our products and core technologies. The strategy also involves seeking broad protection of specific products and their formulation. The ultimate goal is to ensure that Zealand Pharma and its collaborative partners avoid or are aware of patent challenges that could obstruct any of their projects.
Fill in the form below to tip a friend about this page.
When this page is updated you will be updated by e-mail.